Evaluation of the Kirby-Bauer disc diffusion test as a screening test for high-level aminoglycoside resistance in enterococci.
The Kirby-Bauer disc diffusion test was evaluated as a test to detect high-level aminoglycoside (streptomycin, kanamycin, tobramycin, and gentamicin) resistance in isolates of enterococci. The authors found that high-level resistance could not be predicted accurately with the diffusion test.
D000617:Aminoglycosides / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D013293:Enterococcus faecalis / Q000187:drug effects*; D005069:Evaluation Studies as Topic; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D014031:Tobramycin / Q000494:pharmacology
D000617:Aminoglycosides; D007612:Kanamycin; D014031:Tobramycin